- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/454 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
Patent holdings for IPC class A61K 31/454
Total number of patents in this class: 5906
10-year publication summary
|
425
|
445
|
453
|
467
|
503
|
532
|
513
|
450
|
451
|
255
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celgene Corporation | 1412 |
140 |
| Novartis AG | 10963 |
96 |
| Bristol-myers Squibb Company | 4896 |
78 |
| Takeda Pharmaceutical Company Limited | 2703 |
77 |
| Janssen Pharmaceutica N.V. | 3431 |
68 |
| Dana-Farber Cancer Institute, Inc. | 2545 |
64 |
| The Regents of the University of California | 19784 |
50 |
| Merck Sharp & Dohme LLC | 3738 |
50 |
| Abbvie Inc. | 1795 |
49 |
| The Children's Hospital of Philadelphia | 781 |
45 |
| Immunomedics, Inc. | 267 |
42 |
| Boehringer Ingelheim International GmbH | 4702 |
41 |
| Vanda Pharmaceuticals, Inc. | 352 |
41 |
| F. Hoffmann-La Roche AG | 7912 |
40 |
| Taisho Pharmaceutical Co., Ltd. | 856 |
39 |
| Toray Industries, Inc. | 6867 |
37 |
| Pfizer Inc. | 3352 |
36 |
| Mitsubishi Tanabe Pharma Corporation | 581 |
35 |
| Shionogi & Co., Ltd. | 869 |
35 |
| Daiichi Sankyo Company, Limited | 1849 |
34 |
| Other owners | 4809 |